AEMD — AETHLON MEDICAL INC
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-30 | Gikakis Nicolas Director | Shares withheld for tax | 2.2K | 0.82 | 1.8K |
| 2026-06-30 | Shah Chetan Director | Shares withheld for tax | 2.2K | 0.82 | 1.8K |
| 2026-06-30 | BROENNIMAN EDWARD G Director | Shares withheld for tax | 1.1K | 0.82 | 895 |
| 2026-04-17 | Shah Chetan Director | Grant or award | 21.8K | 2.29 | 50.0K |
| 2026-04-17 | BROENNIMAN EDWARD G Director | Grant or award | 21.8K | 2.29 | 50.0K |
| 2026-04-17 | Rossetti Angela Director | Grant or award | 21.8K | 2.29 | 50.0K |
| 2026-04-17 | Gikakis Nicolas Director | Grant or award | 21.8K | 2.29 | 50.0K |
| 2026-03-31 | Shah Chetan Director | Shares withheld for tax | 178 | 2.19 | 390 |
| 2026-03-31 | Gikakis Nicolas Director | Shares withheld for tax | 178 | 2.19 | 390 |
| 2026-03-31 | BROENNIMAN EDWARD G Director | Shares withheld for tax | 89 | 2.19 | 195 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 53.4K | 24.4K |
| Ikarian Capital, LLC | 31.5K | 14.4K |
| Shay Capital LLC | 30.9K | 14.1K |
| XTX Topco Ltd | 29.2K | 13.3K |
| MORGAN STANLEY | 4.5K | 2.0K |
| Tower Research Capital LLC (TRC) | 3.5K | 1.6K |
| UBS Group AG | 2.0K | 895 |
| GROUP ONE TRADING LLC | 31 | 14 |
| BlackRock, Inc. | 22 | 10 |
| Caitong International Asset Management Co., Ltd | 18 | 8 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-13 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-13 | — | on EDGAR ↗ |
| 8-K | 2026-07-31 | 2026-07-30 | on EDGAR ↗ |
| 8-K | 2026-07-08 | 2026-07-06 | on EDGAR ↗ |
| 424B3 | 2026-07-07 | — | on EDGAR ↗ |
| EFFECT | 2026-07-06 | — | on EDGAR ↗ |
| 4 | 2026-07-01 | 2026-06-30 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Aethlon Medical Inc (AEMD) filed form 8-K · 2026-08-13 · SEC EDGAR
- Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program · 2026-08-13
Ask the AI about AEMD
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →